The environmental microbiome testing kit maker, based on Oregon research, has collected series A capital from investors including Western Digital Capital and 3M Ventures.

The liver disease diagnostics spinout has secured the first tranche of a $10m series A investment by Fosun Pharma initially announced in October 2018.

Passage Bio will develop therapies for diseases affecting the central nervous system based on research by James Wilson at Penn, after raising almost $116m in a series A round.

Osage University Partners has contributed to a series A round for Vor Biopharma, an oncology drug developer based on work by Siddhartha Mukherjee at Columbia University.

Venture capital firm Frazier Healthcare Partners has spun out a US-based antibiotics developer with the help of grant funding from a Boston University-operated body and a $8.5m series A round.

Building on research by a former University of Minnesota professor, Torigen Pharmaceuticals has begun in-veterinary testing of its immunooncology vaccine for companion animals.

Danone Manifesto Ventures and ADM Ventures both took part in a series A round for the Montana State University-backed Nasa spinout, which is developing edible proteins.

Smart home technology manufacturer Sousei Technology also collected funding from Aioi Nissay Dowa Insurance in a round that will help it deliver upgrades and additional services.

Virtual reality entertainment operator Sandbox VR has amassed $68m in series A capital from investors including Stanford University.

Australian National University helped supply series A funding to scientific testing device manufacturer Liquid Instruments, which is led by a professor from the university’s College of Science.